Oil prices slide after report Saudi Arabia could step up if Russian output dips under sanctions

Oil prices slide after report Saudi Arabia could step up if Russian output dips under sanctions


All eyes are on whether Saudi Arabia will raise crude production if Russia’s output significantly falls following European Union oil sanctions.

Andrey Rudakov | Bloomberg | Getty Images

Oil prices dropped more than 2% following a report that Saudi Arabia is prepared to raise crude production if Russia’s output significantly falls following European Union sanctions.

The Financial Times reported, citing sources, Saudi Arabia is aware of the risks of a supply shortage and that it is “not in their interests to lose control of oil prices.”

Oil prices fell in the morning of Asia trading hours. International benchmark Brent crude futures were down 2.6% to $113.29 per barrel. U.S. crude futures dropped 2.7% to $112.16 per barrel.

Whilst it’s not an outright promise, Saudi Arabia [has] seemingly thrown the West a bone.

Matt Simpson

market analyst at U.K.-based trading platform City Index

EU leaders on Monday agreed to ban 90% of Russian crude by the end of the year as part of the bloc’s sixth sanctions package on Russia since it invaded Ukraine. That initially sent oil prices higher.

Sources told the FT that Saudi Arabia, OPEC’s de facto leader, has not yet seen genuine shortages in the oil markets. It has so far ignored pressure from Washington to speed up production increases as oil prices soared this year.

But that situation could change as economies globally reopen amid the pandemic recovery, driving demand for crude.

Read more about energy from CNBC Pro

That would include China, the world’s largest oil importer, where major cities are starting to ease restrictions as daily Covid cases taper off.

“Whilst it’s not an outright promise, Saudi Arabia [has] seemingly thrown the West a bone,” Matt Simpson, market analyst at U.K.-based trading platform City Index, wrote in a note following the news.

“This will be well received by Western leaders given inflation – and inflation expectations – remain eye wateringly high, and central banks try to raise rates at the risk of tipping their economies into a recession,” he added.

The FT report comes ahead of a monthly meeting of the OPEC+ alliance on Thursday, which Russia is a part of. Russia is the world’s second largest crude oil exporter behind Saudi Arabia. 

At the same time, some members of OPEC+ are also considering whether to suspend Russia from an oil production deal, The Wall Street Journal reported, citing unnamed OPEC delegates.

The OPEC delegates are reportedly concerned about the growing economic pressure on Russia and its ability to pump more crude to cool soaring prices.



Source

Finland’s IQM to become one of Europe’s first listed quantum companies at .8 billion valuation
World

Finland’s IQM to become one of Europe’s first listed quantum companies at $1.8 billion valuation

European startup IQM is aiming to build powerful quantum computers to rival the likes of Google and IBM. IQM Finland-based quantum computing startup IQM announced plans Monday to become one of Europe’s first publicly listed companies in the sector. IQM will merge with special purpose acquisition company (SPAC), Real Asset Acquisition Corp. (RAAQ) as part […]

Read More
Treasury yields hold steady as investors weigh new Trump tariffs
World

Treasury yields hold steady as investors weigh new Trump tariffs

U.S. Treasury yields were little changed to start the week as investors weighed President Donald Trump’s latest tariffs, after the Supreme Court struck down much of the duties on Friday. At 6:03 a.m. ET, the 10-year Treasury yield was down 1 basis point at 4.075%. The 30-year Treasury bond yield was also less than 1 basis point lower […]

Read More
Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial
World

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial

Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s stock […]

Read More